{
    "clinical_study": {
        "@rank": "82265", 
        "acronym": "TOPCAPP", 
        "brief_summary": {
            "textblock": "To evaluate the change in patient pain perception with the use of a topical compounded pain\n      cream regimen."
        }, 
        "brief_title": "Topical Compounded Pain Creams And Pain Perception (TOPCAPP)", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "detailed_description": {
            "textblock": "This is a prospective,observational,single center, open label study of patients that receive\n      a combination topical compounded analgesic medication with no comparator group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants must be diagnosed with an ICD9 code indicative of chronic pain.\n\n          -  Participants must be starting a new regimen of topical therapy with multiple\n             compounded agents.\n\n          -  Participants must be expecting to receive therapy for at least 12 weeks.\n\n          -  Participants must be between 18 and 65 years of age.\n\n          -  Participants must be able to provide sound written and verbal informed consent.\n\n        Exclusion Criteria:\n\n          -  Participants must not have prior hypersensitivity or adverse events to any of the\n             components in the customized prescription.\n\n          -  Participants must not be pregnant or breastfeeding women.\n\n          -  Participants must not have a diagnosis of cancer within the past 5 years."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Participants with neuropathic or nociceptive chronic pain who are between 18 and 65 years\n        of age prescribed a combination compounded topical analgesic."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862848", 
            "org_study_id": "Medimix Pharm-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Topical Compounded Pain Creams and Pain Perception", 
        "lastchanged_date": "May 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jacksonville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32216"
                }, 
                "name": "The Medimix Specialty Pharmacy, LLC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Topical Compounded Pain Creams And Pain Perception (TOPCAPP)", 
        "overall_official": {
            "affiliation": "Medimix Specialty Pharmacy", 
            "last_name": "Benjamin J Epstein, PharmD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Minimal sample size of 60 persons(maximum n=150)with a diagnosis of chronic pain (n=30 neuropathic and n=30 nociceptive primary pain-type)to determine predictors of a 30% or greater reduction of pain scores evaluated by logistic regression analyses utilizing the Brief Pain Index scores.", 
            "measure": "Perceived pain changes", 
            "safety_issue": "No", 
            "time_frame": "12 Week Study [Baseline, 4,8, and 12 week evaluation]"
        }, 
        "reference": {
            "PMID": "9669787", 
            "citation": "Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998 Jul 8;280(2):147-51. Erratum in: JAMA 1998 Oct 7;280(13):1142."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862848"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To evaluate the change in quality of life using the EuroQol-5D-3L survey.", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "12 Weeks [Baseline,4,8, and 12 week evaluation]"
        }, 
        "source": "Medimix Specialty Pharmacy, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medimix Specialty Pharmacy, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Weeks", 
        "verification_date": "May 2013"
    }
}